Mycophenolate mofetil versus tacrolimus for maintenance of remission in children with frequently relapsing and steroid-dependent nephrotic syndrome: a pilot randomized controlled trial

Study limitation reported by the research below: “Open-label design may introduce bias in secondary outcome assessments such as blood pressure and growth monitoring.”